Concepts (210)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Magnetic Resonance Imaging | 22 | 2024 | 3548 | 1.510 |
Why?
|
| Hydrocephalus | 3 | 2024 | 245 | 1.020 |
Why?
|
| Arnold-Chiari Malformation | 2 | 2024 | 50 | 0.960 |
Why?
|
| Skull Base Neoplasms | 1 | 2022 | 35 | 0.800 |
Why?
|
| Neural Tube Defects | 1 | 2024 | 354 | 0.690 |
Why?
|
| Pons | 2 | 2024 | 32 | 0.600 |
Why?
|
| Leukoencephalopathies | 2 | 2018 | 59 | 0.570 |
Why?
|
| Contrast Media | 6 | 2022 | 470 | 0.530 |
Why?
|
| Societies, Medical | 6 | 2022 | 687 | 0.510 |
Why?
|
| Neck Injuries | 1 | 2014 | 24 | 0.440 |
Why?
|
| Angiography | 1 | 2014 | 216 | 0.430 |
Why?
|
| Nerve Fibers, Myelinated | 1 | 2013 | 80 | 0.430 |
Why?
|
| Child | 29 | 2024 | 24361 | 0.430 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2015 | 579 | 0.410 |
Why?
|
| Cardiopulmonary Bypass | 1 | 2015 | 349 | 0.410 |
Why?
|
| White Matter | 1 | 2015 | 178 | 0.400 |
Why?
|
| Brain Stem | 2 | 2022 | 115 | 0.400 |
Why?
|
| Wounds, Nonpenetrating | 1 | 2014 | 216 | 0.390 |
Why?
|
| Vestibular Nerve | 1 | 2011 | 6 | 0.380 |
Why?
|
| Neuroimaging | 7 | 2023 | 333 | 0.380 |
Why?
|
| Brain | 5 | 2023 | 2979 | 0.360 |
Why?
|
| Nervous System Malformations | 1 | 2011 | 130 | 0.330 |
Why?
|
| Hearing Loss, Sensorineural | 1 | 2011 | 141 | 0.330 |
Why?
|
| Tomography, X-Ray Computed | 8 | 2022 | 2087 | 0.320 |
Why?
|
| Evidence-Based Medicine | 6 | 2022 | 632 | 0.300 |
Why?
|
| Craniocerebral Trauma | 2 | 2020 | 139 | 0.300 |
Why?
|
| Sinusitis | 2 | 2020 | 116 | 0.300 |
Why?
|
| Humans | 44 | 2024 | 124122 | 0.290 |
Why?
|
| Epilepsy | 1 | 2015 | 870 | 0.290 |
Why?
|
| Inflammation | 1 | 2015 | 1421 | 0.280 |
Why?
|
| Diagnosis, Differential | 8 | 2022 | 1879 | 0.270 |
Why?
|
| Retrospective Studies | 14 | 2024 | 16264 | 0.260 |
Why?
|
| Pediatrics | 1 | 2015 | 1157 | 0.260 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2015 | 1112 | 0.260 |
Why?
|
| Infant | 12 | 2024 | 12457 | 0.250 |
Why?
|
| Demyelinating Diseases | 2 | 2018 | 64 | 0.250 |
Why?
|
| Brain Neoplasms | 3 | 2022 | 1210 | 0.240 |
Why?
|
| Cranial Nerves | 1 | 2024 | 19 | 0.240 |
Why?
|
| Skull | 2 | 2022 | 143 | 0.230 |
Why?
|
| Tuberculosis, Spinal | 1 | 2023 | 8 | 0.220 |
Why?
|
| Tuberculosis, Central Nervous System | 1 | 2023 | 10 | 0.220 |
Why?
|
| Skull Base | 1 | 2024 | 54 | 0.220 |
Why?
|
| Actinomycetaceae | 1 | 2023 | 6 | 0.220 |
Why?
|
| Oxidoreductases Acting on CH-CH Group Donors | 1 | 2003 | 8 | 0.220 |
Why?
|
| Actinomycosis | 1 | 2023 | 7 | 0.220 |
Why?
|
| Empyema | 1 | 2023 | 23 | 0.220 |
Why?
|
| Hysterotomy | 1 | 2024 | 126 | 0.220 |
Why?
|
| Laparotomy | 1 | 2024 | 135 | 0.220 |
Why?
|
| Tuberculosis, Meningeal | 1 | 2023 | 29 | 0.220 |
Why?
|
| Brain Diseases, Metabolic, Inborn | 1 | 2003 | 22 | 0.210 |
Why?
|
| Diagnostic Imaging | 2 | 2022 | 276 | 0.210 |
Why?
|
| Basal Ganglia | 1 | 2003 | 55 | 0.210 |
Why?
|
| Globus Pallidus | 1 | 2003 | 64 | 0.210 |
Why?
|
| Heart Defects, Congenital | 1 | 2015 | 1814 | 0.210 |
Why?
|
| Surface Plasmon Resonance | 1 | 2022 | 45 | 0.210 |
Why?
|
| Anti-N-Methyl-D-Aspartate Receptor Encephalitis | 1 | 2023 | 30 | 0.200 |
Why?
|
| Spinal Cord Neoplasms | 1 | 2023 | 71 | 0.200 |
Why?
|
| Fourth Ventricle | 1 | 2022 | 10 | 0.200 |
Why?
|
| Child, Preschool | 12 | 2024 | 14004 | 0.200 |
Why?
|
| Survivorship | 1 | 2022 | 35 | 0.190 |
Why?
|
| Tinnitus | 1 | 2022 | 19 | 0.190 |
Why?
|
| Female | 20 | 2024 | 66250 | 0.190 |
Why?
|
| Cerebellar Ataxia | 1 | 2022 | 65 | 0.190 |
Why?
|
| Diffusion Tensor Imaging | 1 | 2023 | 234 | 0.190 |
Why?
|
| Prognosis | 3 | 2024 | 4608 | 0.190 |
Why?
|
| Dermoid Cyst | 1 | 2021 | 34 | 0.190 |
Why?
|
| Meningomyelocele | 1 | 2024 | 243 | 0.180 |
Why?
|
| Scalp | 1 | 2021 | 57 | 0.180 |
Why?
|
| Proton Therapy | 1 | 2022 | 123 | 0.180 |
Why?
|
| Medical Oncology | 1 | 2022 | 212 | 0.180 |
Why?
|
| Malignant Atrophic Papulosis | 1 | 2020 | 3 | 0.180 |
Why?
|
| Radiology Department, Hospital | 1 | 2020 | 24 | 0.170 |
Why?
|
| Paranasal Sinuses | 1 | 2020 | 20 | 0.170 |
Why?
|
| Fetoscopy | 1 | 2024 | 440 | 0.170 |
Why?
|
| Mitochondrial Diseases | 1 | 2022 | 133 | 0.170 |
Why?
|
| Streptococcal Infections | 1 | 2022 | 243 | 0.170 |
Why?
|
| Anti-Infective Agents | 1 | 2022 | 264 | 0.170 |
Why?
|
| Hematoma, Subdural | 1 | 2019 | 20 | 0.170 |
Why?
|
| Male | 19 | 2024 | 60978 | 0.160 |
Why?
|
| Thrombotic Microangiopathies | 1 | 2020 | 52 | 0.160 |
Why?
|
| Cerebrovascular Disorders | 1 | 2020 | 120 | 0.160 |
Why?
|
| Infant, Newborn | 7 | 2024 | 8180 | 0.160 |
Why?
|
| Spinal Injuries | 1 | 2019 | 29 | 0.160 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 2 | 2023 | 142 | 0.160 |
Why?
|
| Branchio-Oto-Renal Syndrome | 1 | 2018 | 11 | 0.160 |
Why?
|
| Meningitis, Viral | 1 | 2018 | 10 | 0.160 |
Why?
|
| Central Nervous System Viral Diseases | 1 | 2018 | 12 | 0.160 |
Why?
|
| Temporal Bone | 2 | 2018 | 36 | 0.150 |
Why?
|
| Myelitis | 1 | 2018 | 15 | 0.150 |
Why?
|
| Cochlea | 1 | 2018 | 85 | 0.150 |
Why?
|
| Neuromuscular Diseases | 1 | 2018 | 55 | 0.150 |
Why?
|
| Polyneuropathies | 1 | 2018 | 29 | 0.140 |
Why?
|
| Ipilimumab | 1 | 2018 | 45 | 0.140 |
Why?
|
| Brain Injuries | 1 | 2003 | 765 | 0.140 |
Why?
|
| West Nile virus | 1 | 2018 | 117 | 0.140 |
Why?
|
| Child Abuse | 1 | 2019 | 193 | 0.140 |
Why?
|
| Betacoronavirus | 1 | 2020 | 286 | 0.130 |
Why?
|
| Chromosomes, Human, Pair 17 | 1 | 2018 | 369 | 0.130 |
Why?
|
| West Nile Fever | 1 | 2018 | 139 | 0.130 |
Why?
|
| Antineoplastic Agents, Immunological | 1 | 2018 | 109 | 0.130 |
Why?
|
| Pregnancy | 3 | 2024 | 7164 | 0.130 |
Why?
|
| Temporomandibular Joint Disorders | 1 | 2016 | 12 | 0.130 |
Why?
|
| Nervous System Diseases | 1 | 2020 | 373 | 0.130 |
Why?
|
| Chromosome Deletion | 1 | 2018 | 645 | 0.120 |
Why?
|
| Hearing Loss, Unilateral | 1 | 2014 | 7 | 0.120 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 356 | 0.120 |
Why?
|
| Hearing Aids | 1 | 2014 | 17 | 0.120 |
Why?
|
| Transverse Sinuses | 1 | 2014 | 1 | 0.120 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 370 | 0.120 |
Why?
|
| Lateral Sinus Thrombosis | 1 | 2014 | 2 | 0.120 |
Why?
|
| Vertebral Artery | 1 | 2014 | 25 | 0.110 |
Why?
|
| Glasgow Coma Scale | 1 | 2014 | 208 | 0.110 |
Why?
|
| Intracranial Arteriosclerosis | 1 | 2013 | 9 | 0.110 |
Why?
|
| Diagnostic Techniques, Ophthalmological | 1 | 2014 | 102 | 0.110 |
Why?
|
| Prenatal Diagnosis | 1 | 2018 | 597 | 0.110 |
Why?
|
| Accidents, Traffic | 1 | 2014 | 108 | 0.110 |
Why?
|
| Neck | 1 | 2014 | 137 | 0.100 |
Why?
|
| Optic Nerve Diseases | 1 | 2014 | 89 | 0.100 |
Why?
|
| Sinus Thrombosis, Intracranial | 1 | 2013 | 48 | 0.100 |
Why?
|
| Pandemics | 1 | 2020 | 1094 | 0.100 |
Why?
|
| Magnetic Resonance Angiography | 1 | 2013 | 161 | 0.100 |
Why?
|
| Adolescent | 7 | 2024 | 19247 | 0.100 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2014 | 366 | 0.100 |
Why?
|
| Audiometry | 1 | 2011 | 21 | 0.090 |
Why?
|
| Sampling Studies | 1 | 2011 | 76 | 0.090 |
Why?
|
| Ataxia | 2 | 2022 | 168 | 0.090 |
Why?
|
| Melanoma | 1 | 2018 | 835 | 0.090 |
Why?
|
| Cochlear Implantation | 1 | 2011 | 50 | 0.090 |
Why?
|
| Risk Factors | 2 | 2015 | 10241 | 0.090 |
Why?
|
| Survivors | 2 | 2022 | 322 | 0.080 |
Why?
|
| Rare Diseases | 1 | 2011 | 192 | 0.080 |
Why?
|
| Cytokines | 1 | 2015 | 1285 | 0.080 |
Why?
|
| Organometallic Compounds | 2 | 2013 | 104 | 0.080 |
Why?
|
| Syndrome | 1 | 2011 | 1120 | 0.080 |
Why?
|
| United States | 5 | 2021 | 10856 | 0.070 |
Why?
|
| Seizures | 2 | 2023 | 876 | 0.070 |
Why?
|
| Electroencephalography | 1 | 2011 | 864 | 0.070 |
Why?
|
| Biomarkers | 1 | 2015 | 3046 | 0.060 |
Why?
|
| Prospective Studies | 1 | 2015 | 6117 | 0.060 |
Why?
|
| Meninges | 1 | 2023 | 18 | 0.060 |
Why?
|
| Heterocyclic Compounds | 1 | 2003 | 14 | 0.050 |
Why?
|
| Glutaryl-CoA Dehydrogenase | 1 | 2003 | 3 | 0.050 |
Why?
|
| Gadolinium DTPA | 1 | 2003 | 47 | 0.050 |
Why?
|
| Joint Diseases | 1 | 2003 | 33 | 0.050 |
Why?
|
| Spin Labels | 1 | 2023 | 39 | 0.050 |
Why?
|
| Streptococcus gallolyticus | 1 | 2022 | 3 | 0.050 |
Why?
|
| Gadolinium | 1 | 2003 | 104 | 0.050 |
Why?
|
| Streptococcus | 1 | 2022 | 61 | 0.050 |
Why?
|
| Verbal Learning | 1 | 2022 | 66 | 0.050 |
Why?
|
| Protons | 1 | 2022 | 92 | 0.050 |
Why?
|
| Intelligence Tests | 1 | 2022 | 57 | 0.050 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 1 | 2023 | 149 | 0.050 |
Why?
|
| Penicillins | 1 | 2022 | 154 | 0.050 |
Why?
|
| Spinal Cord | 1 | 2023 | 300 | 0.050 |
Why?
|
| Organizational Objectives | 1 | 2020 | 33 | 0.040 |
Why?
|
| Gestational Age | 1 | 2024 | 1160 | 0.040 |
Why?
|
| Nasopharyngeal Neoplasms | 1 | 2020 | 57 | 0.040 |
Why?
|
| Biological Factors | 1 | 2020 | 27 | 0.040 |
Why?
|
| Multiple Sclerosis | 1 | 2003 | 330 | 0.040 |
Why?
|
| Cranial Nerve Diseases | 1 | 2020 | 26 | 0.040 |
Why?
|
| Gait Disorders, Neurologic | 1 | 2020 | 38 | 0.040 |
Why?
|
| Personal Protective Equipment | 1 | 2020 | 54 | 0.040 |
Why?
|
| Urinary Incontinence | 1 | 2020 | 70 | 0.040 |
Why?
|
| Hospitals | 1 | 2022 | 390 | 0.040 |
Why?
|
| Workplace | 1 | 2020 | 67 | 0.040 |
Why?
|
| Nitriles | 1 | 2020 | 146 | 0.040 |
Why?
|
| Headache | 1 | 2020 | 106 | 0.040 |
Why?
|
| Fatal Outcome | 1 | 2020 | 355 | 0.040 |
Why?
|
| Neuropsychological Tests | 1 | 2022 | 918 | 0.040 |
Why?
|
| Sensitivity and Specificity | 2 | 2014 | 2037 | 0.040 |
Why?
|
| Adult | 4 | 2023 | 29322 | 0.040 |
Why?
|
| Central Nervous System | 1 | 2020 | 251 | 0.040 |
Why?
|
| Cerebellum | 1 | 2022 | 411 | 0.040 |
Why?
|
| 14-3-3 Proteins | 1 | 2018 | 54 | 0.040 |
Why?
|
| 1-Alkyl-2-acetylglycerophosphocholine Esterase | 1 | 2018 | 92 | 0.040 |
Why?
|
| Cerebral Aqueduct | 1 | 2018 | 10 | 0.040 |
Why?
|
| Family | 1 | 2021 | 562 | 0.040 |
Why?
|
| Pyrazoles | 1 | 2020 | 305 | 0.040 |
Why?
|
| Cognition | 1 | 2022 | 707 | 0.040 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2018 | 244 | 0.030 |
Why?
|
| Herpesvirus 4, Human | 1 | 2020 | 676 | 0.030 |
Why?
|
| Pyrimidines | 1 | 2020 | 369 | 0.030 |
Why?
|
| Skin | 1 | 2020 | 517 | 0.030 |
Why?
|
| Mitochondria | 1 | 2022 | 677 | 0.030 |
Why?
|
| Drug Therapy, Combination | 1 | 2020 | 1162 | 0.030 |
Why?
|
| Antibodies, Monoclonal, Humanized | 1 | 2020 | 504 | 0.030 |
Why?
|
| Meningeal Neoplasms | 1 | 2018 | 184 | 0.030 |
Why?
|
| Follow-Up Studies | 1 | 2024 | 5132 | 0.030 |
Why?
|
| Suture Anchors | 1 | 2014 | 3 | 0.030 |
Why?
|
| Treatment Outcome | 2 | 2024 | 12275 | 0.030 |
Why?
|
| Fetus | 1 | 2018 | 584 | 0.030 |
Why?
|
| Optic Disk | 1 | 2014 | 44 | 0.030 |
Why?
|
| Disease Progression | 1 | 2020 | 2047 | 0.030 |
Why?
|
| Single-Blind Method | 1 | 2014 | 231 | 0.030 |
Why?
|
| Texas | 1 | 2022 | 3580 | 0.030 |
Why?
|
| Observer Variation | 1 | 2014 | 299 | 0.030 |
Why?
|
| Meglumine | 1 | 2013 | 14 | 0.030 |
Why?
|
| Constriction, Pathologic | 1 | 2014 | 241 | 0.030 |
Why?
|
| Subtraction Technique | 1 | 2013 | 36 | 0.030 |
Why?
|
| Optic Nerve | 1 | 2014 | 115 | 0.030 |
Why?
|
| Random Allocation | 1 | 2013 | 435 | 0.020 |
Why?
|
| Prosthesis Design | 1 | 2014 | 682 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2018 | 4778 | 0.020 |
Why?
|
| Prevalence | 1 | 2014 | 2444 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2013 | 2139 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2014 | 2862 | 0.020 |
Why?
|
| Middle Aged | 2 | 2020 | 26583 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2014 | 3265 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2013 | 6465 | 0.010 |
Why?
|
| Aged | 1 | 2013 | 19526 | 0.010 |
Why?
|